Obermatt
See Similar Stocks →

Flags

Financial distress

FamiCord

GER:V3V · DE000A0BL849
Health Care Providers & ServicesSmall

360

39
EV / EBIT14
Price / Owner Earnings78
Owner Earnings Yield1
Dividend Yield1
Price/Sales88
EV / Gross Profit85
Price/Book5
Return on Capital54
Cash Return on Capital12
Return on Equity8
EBIT Margin44
Gross Profitability47
Accruals22
Owner Earnings Margin30
Sales growth37
Profit growth51
Reinvestment45
Price momentum50
Debt load21
Refinancing6
Debt Payback1
Liquidity52
Analyst ratings100
Opinion Changes50
Price Target Upside89
Market mood1
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

FamiCord doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryLuxembourg
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeXTRA
Founded2004
Employees19
Websitefamicord.com
ISINDE000A0BL849
Last UpdateApr 2, 2026
Indices
CDAX (Germany)
Themes
Health DiagnosticsHematologyFertilityStem Cell TherapyGeneticsReproductive HealthHealth CareMedicalPharmaceutical

Description

FamiCord AG (FamiCord) operates prominently in the field of stem cell storage and processing, offering innovative solutions for the preservation of stem cells derived from umbilical cord blood and tissue. The company is dedicated to enhancing the qua…

Analysis

Weak and unloved

FamiCord AG scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is stretched. The company scores 6/20 on our value-creation score: not creating value. Analysts lean positive.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
1
2023202420252026

All-time high

64

Jan 2023

All-time low

1

Jun 2026

Average rank

15

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
88
93
84
71
Price/Earnings
1
43
1
25
Price/Book
5
59
32
79
Dividend Yield
1
1
1
1
Value (overall)
12
57
16
42

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare FamiCord with its peers
Mereo BioPharma Group
NAQ:MREO
51
CountryUK
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
SHL Telemedicine
SWX:SHLTN
24
CountryIsrael
IndustryHealth Care Providers & Services
SizeX-Small
Full Stock Analysis →
Tiziana Life Sciences
NAQ:TLSA
67
CountryUK
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Valneva
PAR:VLA
21
CountryFrance
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Prothena Corporation
NSQ:PRTA
39
CountryIreland
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
BeOne Medicines
SHH:688235
91
CountrySwitzerland
IndustryBiotechnology
SizeX-Large
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →